Global Iodinated Contrast Media in Interventional X-Ray Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Dec 2019
  • Global
  • 350 Pages
  • No of Tables: 321
  • No of Figures: 71

Global Iodinated Contrast Media in Interventional X-Ray Market By Route of Administration (Intravenous, Oral, Rectal, Others), Indication (Cardiology, Neurology, General Surgery, Oncology, Urology), Agent Type (Non-Ionic, Ionic), End User (Hospital, Specialty Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research & Academic Institutes), Country ( U.S., Canada, Mexico,, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Russia, Belgium, Turkey, Rest Of Europe, China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, UAE, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa) Market Trends and  Forecast to 2027

Market Analysis and Insights: Global Iodinated Contrast Media in Interventional X-Ray Market

Iodinated contrast media in Interventional X-ray market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.3% in the forecast period of 2020 to 2027and expected to reach USD 3,160.98 million by 2027 from USD 2,108.76 million in 2019. Large number of approvals for iodinated agents and increasing number of chronic diseases is driving the iodinated contrast media in interventional x-ray market.

Increasing prevalence of chronic disease such as growing preference for interventional diagnosis across the globe has increased the adoption of iodinated contrast media. For instance, According to World Health Organization, there were an estimated 17.9 million deaths in 2016 due to cardiovascular diseases; cardiovascular diseases are one of the main causes of deaths around the world.

 Growing preference towards iodinated contrast media from traditional contrast media and large number of approvals for iodinated agents will drive the market and create new opportunities for the growth during the forecast period. For instance, In March 2017, the Food and Drug Administration (FDA) approved GE Healthcare Visipaque (iodixanol) imaging agent. The need for diagnostic imaging has increased resulting to the contribution to the medical costs and also by providing exposure to the ionizing radiation. Furthermore, iodinated contrast media in Interventional X-ray is witnessing significant growth as demand of clinical and diagnostic increases for various indications. Growing healthcare expenditure and strategic government reforms is also leading to high adoption of minimally invasive interventional surgeries which further boom the growth market.

This iodinated contrast media in interventional X-ray market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Iodinated Contrast Media in Interventional X-Ray Market Scope and Market Size

Global iodinated contrast media in interventional X-ray market is segmented of the basis of route of administration, indication, agent type and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • Based on route of administration, iodinated contrast media in interventional X-ray market is segmented into oral, intravenous, rectal, others. Intravenous segment is dominating the market because it is widely adopted among healthcare professionals due to its efficacy, shorter examination time and safety. In addition, innovation in drug delivery such as syringeless injectors also increases demand of intravenous mode.
  • Based on agent type, iodinated contrast media in interventional X-ray market is segmented into ionic and non-ionic. Non-ionic segment is dominating the market because of low osmolarity and fewer side effects of non-ionic agents as compared to alternative agents. In addition,   rising awareness and various advantages associated with non-ionic agents will increase its acceptability and utilization in interventional diagnostics procedure.
  • Based on indication, iodinated contrast media in interventional X-ray market is segmented into cardiology, oncology, urology, general surgery and neurology. Cardiology segment is dominating the market due to high penetration of iodinated contrast agents in interventional cardiovascular diagnostics and growing popularity of non-ionic stable iodinated agents for improved diagnosis.
  • Based on end user, the market is segmented into hospital, specialty clinics, diagnostic centers, ambulatory surgical centres, research & academic institutes. Hospital segment is dominating the market throughout the forecast period due to high volume of interventional radiology diagnostic procedure performed in the hospital. Additionally, competences of hospitals for acquiring cutting edge technologies and trained professionals in the interventional radiology units has created an opportunity for the highest revenue generation.  

Iodinated Contrast Media in Interventional X-Ray Market Country Level Analysis

Iodinated contrast media in interventional X-ray market is analysed and market size information is provided by country, route of administration, indication, agent type and end user as referenced above.

The countries covered in the iodinated contrast media in interventional X-ray market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, South Africa, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil and Rest of South America as part of South America.

Country Level Analysis, By Route of Administration

Iodinated Contrast Media in Interventional X-Ray Market

North America dominates the iodinated contrast media in interventional X-ray market as the U.S. is leader in iodinated contrast media in interventional X-ray. In North America, due to high penetration of iodinated contrast materials in CT procedures and availability of non-ionic stable iodinated agents for better diagnosis, this region is dominating the iodinated contrast media in interventional X-ray. Asia-Pacific is growing with the highest CAGR due to high adoption of imaging techniques and rising availability of non-ionic stable iodinated agents for improved diagnosis. Additionally, the increasing number of healthcare expenditure and increasing number of hospitals and imaging centers in China and India upsurge demand of iodinated contrast media in interventional X-ray.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Extensive Research and Development Activities in Iodinated Contrast Media in Interventional X-Ray

Global iodinated contrast media in interventional X-ray market also provides you with detailed market analysis for every country growth in medical industry with iodinated contrast media in interventional X-ray demand impact of technological development in iodinated contrast media and changes in regulatory scenarios with their support for the iodinated contrast media in interventional X-ray market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Iodinated Contrast Media in Interventional X-Ray Market Share Analysis

Iodinated contrast media in interventional X-ray market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, concept cars, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to iodinated contrast media in interventional X-ray market.

The major players covered in the report are Bayer AG, Iso-Tex Diagnostics, Inc., Bracco Diagnostic Inc., Novalek Pharmaceuticals Pvt. Ltd., iMAX, Taejoon Pharm, Unijules Medicals Ltd, General Electric, Guerbet LLC, J.B.Chemicals & Pharmaceuticals Ltd among others players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many business expansion and developments are also initiated by the companies worldwide which are also accelerating the iodinated contrast media in interventional X-ray market.

For instance,

  •  In June 2019, General Electric and Daiichi Sankyo Company did an agreement that Daiichi Sankyo to transfer authorization of marketing rights for four diagnostic imaging agents in Japan to GE Healthcare. After completing this agreement the company expanded their diagnostic imaging agents in the Japan. This will help company to expand their business in the market.
  • In July 2018, General Electric announced that they have launched ready-to-drink oral solution of iodinated contrast agent which can help physicians improving the visualization of diagnostic abdominal gastrointestinal tract. With this new formulation of contrast agent the company enhanced its choice of options for oral contrast agent which is available to radiologists and patients.

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for iodinated contrast media in interventional X-ray through expanded model range.

Customization Available : Global Iodinated Contrast Media in Interventional X-Ray Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 LIST OF FDA APPROVED NON-IONIC IODINATED AGENTS

TABLE 2 LIST OF FDA APPROVED IONIC IODINATED AGENTS

TABLE 3 COST OF CONTRAST MEDIA

TABLE 4 LIST OF UPCOMING GENERIC CONTRAST MEDIA AGENTS

TABLE 5 DOSAGE OF CONTRAS MEDIA TO BE TAKEN AS PER PATIENT’S WEIGHT

TABLE 6 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 7 GLOBAL INTRAVENOUS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 8 GLOBAL ORAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 9 GLOBAL RECTAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 10 GLOBAL OTHERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 11 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 12 GLOBAL HOSPITAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 GLOBAL SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 GLOBAL SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 15 GLOBAL DIAGNOSTIC CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 16 GLOBAL AMBULATORY SURGICAL CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 GLOBAL RESEARCH & ACADEMIC INSTITUTES IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 19 GLOBAL CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 GLOBAL CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 21 GLOBAL NEUROLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 GLOBAL GENERAL SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 GLOBAL ONCOLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 GLOBAL UROLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 26 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITER)

TABLE 27 GLOBAL NON-IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 GLOBAL IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 29 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAYS MARKET,  BY GEOGRAPHY, 2018-2027 (USD MILLION)

TABLE 30 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 31 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 32 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 33 NORTH AMERICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 34 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 35 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 36 NORTH AMERICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 37 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 38 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 39 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 40 U.S. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 41 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 42 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 43 U.S. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 44 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 45 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 46 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 47 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 48 CANADA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 49 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 50 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 51 CANADA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 52 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 53 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 54 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 55 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 56 MEXICO CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 57 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 58 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 59 MEXICO SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 60 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 61 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 62 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 63 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 64 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 65 EUROPE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 66 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 67 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 68 EUROPE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 69 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 70 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 71 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 72 GERMANY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 73 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 74 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 75 GERMANY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 76 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 77 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 78 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 79 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 80 U.K. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 81 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 82 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 83 U.K. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 84 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 85 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 86 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 87 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 88 FRANCE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 89 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 90 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 91 FRANCE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 92 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 93 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 94 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 95 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 96 ITALY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 97 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 98 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 99 ITALY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 100 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 101 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 102 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 103 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 104 SPAIN CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 105 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 106 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 107 SPAIN SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 108 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 109 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 110 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 111 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 112 SWITZERLAND CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 113 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 114 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 115 SWITZERLAND SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 116 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 117 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 118 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 119 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 120 NETHERLANDS CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 121 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 122 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 123 NETHERLANDS SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 124 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 125 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 126 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 127 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 128 RUSSIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 129 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 130 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 131 RUSSIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 132 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 133 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 134 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 135 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 136 BELGIUM CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 137 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 138 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 139 BELGIUM SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 140 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 141 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 142 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 143 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 144 TURKEY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 145 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 146 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 147 TURKEY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 148 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 149 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 150 REST OF EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 151 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 152 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 153 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 154 ASIA-PACIFIC CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 155 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 156 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 157 ASIA-PACIFIC SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 158 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 159 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 160 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 161 CHINA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 162 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 163 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 164 CHINA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 165 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 166 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 167 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 168 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 169 JAPAN CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 170 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 171 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 172 JAPAN SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 173 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 174 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 175 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 176 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 177 SOUTH KOREA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 178 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 179 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 180 SOUTH KOREA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 181 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 182 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 183 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 184 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 185 INDIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 186 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 187 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 188 INDIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 189 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 190 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 191 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 192 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 193 AUSTRALIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 194 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 195 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 196 AUSTRALIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 197 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 198 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 199 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 200 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 201 SINGAPORE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 202 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 203 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 204 SINGAPORE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 205 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 206 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 207 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 208 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 209 THAILAND CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 210 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 211 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 212 THAILAND SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 213 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 214 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 215 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 216 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 217 MALAYSIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 218 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 219 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 220 MALAYSIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 221 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 222 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 223 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 224 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 225 INDONESIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 226 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 227 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 228 INDONESIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 229 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 230 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 231 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 232 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 233 PHILIPPINES CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 234 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 235 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 236 PHILIPPINES SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 237 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 238 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 239 REST OF ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 240 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 241 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 242 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 243 SOUTH AMERICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 244 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 245 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 246 SOUTH AMERICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 247 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 248 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 249 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 250 BRAZIL CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 251 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 252 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 253 BRAZIL SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 254 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 255 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 256 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 257 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 258 ARGENTINA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 259 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 260 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 261 ARGENTINA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 262 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 263 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 264 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 265 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 266 PERU CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 267 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 268 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 269 PERU SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 270 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 271 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 272 REST OF SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 273 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 274 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 275 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 276 MIDDLE EAST AND AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 277 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 278 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 279 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 280 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 281 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 282 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 283 U.A.E. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 284 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 285 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 286 U.A.E. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 287 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 288 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 289 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 290 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 291 SAUDI ARABIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 292 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 293 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 294 SAUDI ARABIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 295 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 296 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 297 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 298 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 299 EGYPT CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 300 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 301 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 302 EGYPT SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 303 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 304 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 305 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 306 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 307 SOUTH AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 308 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 309 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 310 SOUTH AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 311 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 312 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 313 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 314 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 315 ISRAEL CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 316 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 317 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 318 ISRAEL SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 319 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 320 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 321 REST OF MIDDLE EAST & AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions